Eliana Clark - Net Worth and Insider Trading

Eliana Clark Net Worth

The estimated net worth of Eliana Clark is at least $1 Million dollars as of 2024-11-05. Eliana Clark is the EVP, Chief Technical Officer of Intellia Therapeutics Inc and owns about 71,470 shares of Intellia Therapeutics Inc (NTLA) stock worth over $1 Million. Details can be seen in Eliana Clark's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Eliana Clark has not made any transactions after 2024-07-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Eliana Clark

To

Eliana Clark Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Eliana Clark owns 1 companies in total, including Intellia Therapeutics Inc (NTLA) .

Click here to see the complete history of Eliana Clark’s form 4 insider trades.

Insider Ownership Summary of Eliana Clark

Ticker Comapny Transaction Date Type of Owner
NTLA Intellia Therapeutics Inc 2024-07-01 EVP & Chief Technical Officer

Eliana Clark Latest Holdings Summary

Eliana Clark currently owns a total of 1 stock. Eliana Clark owns 71,470 shares of Intellia Therapeutics Inc (NTLA) as of July 1, 2024, with a value of $1 Million.

Latest Holdings of Eliana Clark

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
NTLA Intellia Therapeutics Inc 2024-07-01 71,470 15.25 1,089,918

Holding Weightings of Eliana Clark


Eliana Clark Form 4 Trading Tracker

According to the SEC Form 4 filings, Eliana Clark has made a total of 5 transactions in Intellia Therapeutics Inc (NTLA) over the past 5 years, including 0 buys and 5 sells. The most-recent trade in Intellia Therapeutics Inc is the sale of 405 shares on July 1, 2024, which brought Eliana Clark around $9,287.

Insider Trading History of Eliana Clark

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Eliana Clark Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Eliana Clark Ownership Network

Ownership Network List of Eliana Clark

No Data

Ownership Network Relation of Eliana Clark

Insider Network Chart

Eliana Clark Owned Company Details

What does Intellia Therapeutics Inc do?

Who are the key executives at Intellia Therapeutics Inc?

Eliana Clark is the EVP & Chief Technical Officer of Intellia Therapeutics Inc. Other key executives at Intellia Therapeutics Inc include EVP & Chief Scientific Officer Laura Sepp-lorenzino , EVP & Chief Business Officer Derek Hicks , and director & President and CEO John M. Leonard .

Intellia Therapeutics Inc (NTLA) Insider Trades Summary

Over the past 18 months, Eliana Clark made 4 insider transaction in Intellia Therapeutics Inc (NTLA) with a net sale of 10,373. Other recent insider transactions involving Intellia Therapeutics Inc (NTLA) include a net sale of 2,397 shares made by Muna Bhanji , a net sale of 7,807 shares made by Laura Sepp-lorenzino , and a net sale of 19,223 shares made by John M. Leonard .

In summary, during the past 3 months, insiders sold 2,012 shares of Intellia Therapeutics Inc (NTLA) in total and bought 0 shares, with a net sale of 2,012 shares. During the past 18 months, 62,207 shares of Intellia Therapeutics Inc (NTLA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 62,207 shares.

Intellia Therapeutics Inc (NTLA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Intellia Therapeutics Inc Insider Transactions

No Available Data

Eliana Clark Mailing Address

Above is the net worth, insider trading, and ownership report for Eliana Clark. You might contact Eliana Clark via mailing address: C/o Intellia Therapeutics, Inc., 40 Erie Street, Suite 130, Cambridge Ma 02139.